Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (OTCQB:TTNP)

0.728
Delayed Data
As of Sep 04
 -0.012 / -1.62%
Today’s Change
0.44
Today|||52-Week Range
0.99
+57.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$81.6M

Company Description

Pro-Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which is developing proprietary therapeutics primarily for the treatment of serious medical disorders. It uses proprietary long-term drug delivery platform ProNeura and focuses primarily on innovative treatments for select chronic diseases. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.

Contact Information

Titan Pharmaceuticals, Inc.
400 Oyster Point Boulevard
South San Francisco California 94080-1921
P:(650) 244-4990
Investor Relations:

Employees

Shareholders

Individual stakeholders12.52%
Mutual fund holders--
Other institutional--

Top Executives

Sunil BhonslePresident, Secretary & Director
Brian CrowleyVice President-Finance
Katherine L. Glassman-BeebeChief Development Officer & Executive VP
Stephen KilmerHead-Investor Relations
Susan Ajay ThomasHead-Media Relations